Recombinant Staphylococcus aureus 60 kDa chaperonin (groL), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format, but if you have special requirements, please note them when ordering, and we will try to accommodate your request.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributors for specific delivery times. All proteins are shipped with standard blue ice packs. If dry ice is required, please contact us in advance, as additional charges will apply.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on factors such as storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form is stable for 6 months at -20°C/-80°C, and the lyophilized form is stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
groL; groEL; SA183660 kDa chaperonin; GroEL protein; Protein Cpn60
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Staphylococcus aureus (strain N315)
Target Names
groL
Uniprot No.

Target Background

Function
This protein, along with its co-chaperonin GroES, plays a vital role in protein folding. The GroEL-GroES system creates a nano-cage that encapsulates unfolded proteins, providing an optimal environment for promoting and accelerating protein folding.
Database Links

KEGG: sau:SA1836

Protein Families
Chaperonin (HSP60) family
Subcellular Location
Cytoplasm.

Q&A

What is the optimal storage condition for Recombinant Staphylococcus aureus 60 kDa chaperonin (groL)?

Recombinant Staphylococcus aureus 60 kDa chaperonin (groL) should be stored at -20°C for regular use. For extended storage periods, it is recommended to conserve the protein at either -20°C or -80°C to maintain stability and activity. Repeated freezing and thawing cycles significantly compromise protein integrity and should be avoided. For working solutions, store aliquots at 4°C for up to one week to minimize degradation while maintaining accessibility for experiments .

What is the recommended reconstitution protocol for lyophilized Recombinant Staphylococcus aureus 60 kDa chaperonin (groL)?

The optimal reconstitution protocol involves briefly centrifuging the vial prior to opening to ensure all contents are at the bottom. Reconstitute the protein in deionized sterile water to achieve a concentration between 0.1-1.0 mg/mL. For long-term storage stability, add glycerol to a final concentration between 5-50% (with 50% being the standard recommendation for most applications) and create multiple aliquots before storing at -20°C/-80°C .

How can I verify the purity of Recombinant Staphylococcus aureus 60 kDa chaperonin (groL)?

The purity of Recombinant Staphylococcus aureus 60 kDa chaperonin (groL) can be verified using SDS-PAGE analysis, with the commercial product typically showing >85% purity. When conducting validation experiments, it is advisable to run both reducing and non-reducing conditions to assess potential aggregation or degradation. Western blot analysis using anti-GroL antibodies can provide additional confirmation of protein identity, similar to the immunoblot approach used for detecting SdrD expression in both S. aureus and L. lactis systems .

How does Recombinant Staphylococcus aureus 60 kDa chaperonin (groL) compare functionally to other staphylococcal proteins in adhesion assays?

Unlike adhesins such as SdrD that demonstrate direct interaction with host proteins like Desmoglein 1 (Dsg1), Staphylococcus aureus 60 kDa chaperonin (groL) has not been extensively characterized for direct host-pathogen interactions. When designing adhesion assays, researchers should consider that S. aureus expresses multiple microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) that may create functional redundancy in experimental systems. To address this challenge, heterologous expression systems (similar to those using L. lactis for SdrD studies) can isolate the specific contribution of groL in host-cell interactions by eliminating this redundancy .

What are the methodological considerations for using Recombinant Staphylococcus aureus 60 kDa chaperonin (groL) in host-pathogen interaction studies?

When investigating potential interactions between Staphylococcus aureus 60 kDa chaperonin (groL) and host targets, researchers should employ multiple complementary approaches to establish specificity and biological relevance. These should include:

  • Direct binding assays with immobilized potential target proteins

  • Competition-based studies with soluble protein pre-incubation

  • Flow cytometry verification of binding to relevant host cells

  • Gain/loss-of-function genetic approaches (e.g., knockout mutants and complementation)

  • Heterologous expression systems to eliminate functional redundancy

This multi-faceted approach, similar to that used for characterizing SdrD-Dsg1 interactions, provides robust evidence for specific protein-protein interactions while controlling for non-specific binding phenomena .

How can I design experiments to investigate potential extracellular roles of Recombinant Staphylococcus aureus 60 kDa chaperonin (groL)?

While the intracellular role of chaperonins in protein folding is well established, investigating potential extracellular functions requires careful experimental design. Consider the following methodological approach:

Experimental ApproachMethodologyControlsExpected Outcome
Surface expressionFlow cytometry with anti-groL antibodiesIsotype control antibodiesQuantification of surface-expressed groL
Host cell bindingFluorescently-labeled recombinant groLHeat-denatured proteinIdentification of potential target cells
Target identificationPull-down assays and mass spectrometryNon-specific protein (e.g., BSA)Identification of interacting host proteins
Functional validationBlocking antibodies in infection modelsNon-specific antibodiesReduction in specific virulence phenotypes
Genetic approachesConditional mutants (to avoid lethality)Wild-type complementationPhenotypic characterization

This approach mirrors the experimental strategy used for identifying unexpected extracellular roles of other intracellular proteins like TPI, which has been suggested to have plasminogen binding activity relevant to staphylococcal invasion .

What experimental design approaches are most appropriate for studying Recombinant Staphylococcus aureus 60 kDa chaperonin (groL) in vitro?

When designing experiments involving Recombinant Staphylococcus aureus 60 kDa chaperonin (groL), researchers should implement a systematic approach with the following considerations:

  • Establish clear independent and dependent variables related to groL function

  • Formulate specific, testable hypotheses about groL activity

  • Design treatments that manipulate groL concentration, activity, or availability

  • Implement appropriate randomization strategies to minimize bias

  • Include essential controls (negative, positive, and vehicle)

For complex experimental designs, consider randomized block designs where test subjects/samples are first grouped according to shared characteristics before random assignment to treatment conditions. This approach reduces within-group variability and increases statistical power, particularly when working with heterogeneous biological systems .

How can I develop a reliable immunodetection system for Staphylococcus aureus 60 kDa chaperonin (groL) in complex biological samples?

Developing a robust immunodetection system requires careful consideration of antibody specificity and validation procedures. Based on approaches used for other staphylococcal proteins:

  • Generate polyclonal or monoclonal antibodies against purified recombinant groL

  • Validate antibody specificity using wild-type S. aureus and isogenic groL mutants (if viable)

  • Confirm absence of cross-reactivity with human homologs or other bacterial species

  • Optimize detection conditions for different sample types (cell lysates, serum, tissue extracts)

  • Develop quantitative standards using purified recombinant protein

For western blot applications, parallel detection of control proteins (such as GroL as used for SdrD validation) provides important loading controls and confirms sample integrity .

What are the key considerations for investigating potential immunogenicity of Recombinant Staphylococcus aureus 60 kDa chaperonin (groL)?

When studying the immunogenic properties of Recombinant Staphylococcus aureus 60 kDa chaperonin (groL), researchers should consider:

  • Immunization protocol design:

    • Protein dosage (e.g., 80 μg for primary immunization, 40 μg for boosters)

    • Adjuvant selection (e.g., Freund's adjuvant for primary, incomplete Freund's for boosters)

    • Administration route (e.g., i.p. for primary, s.c. for boosters)

    • Immunization schedule (e.g., boosters at days 33 and 56)

  • Immune response assessment:

    • Measurement of antibody titers against the recombinant protein

    • Western blot analysis to confirm specificity

    • Functional assays to determine protective potential

This approach parallels successful immunization strategies used for other staphylococcal proteins like CgoX and TPI, which generated high IgG titers with protective capacity .

How should conflicting results in Staphylococcus aureus 60 kDa chaperonin (groL) functional studies be reconciled?

When faced with conflicting results in functional studies involving Recombinant Staphylococcus aureus 60 kDa chaperonin (groL), implement the following analytical framework:

  • Evaluate methodological differences between studies:

    • Protein source and purity (>85% vs. higher purity preparations)

    • Tag systems used (position and type of tags can affect function)

    • Buffer compositions and additives

    • Experimental conditions (temperature, pH, salt concentration)

  • Consider biological context:

    • Cell lines or primary cells used in experiments

    • Expression levels of potential interaction partners

    • Presence of competitive binding proteins

    • Post-translational modifications of recombinant vs. native protein

  • Apply advanced validation approaches:

    • Multiple complementary techniques to verify interactions

    • Dose-response relationships to establish specificity

    • Knockout/complementation studies to confirm functional relationships

    • Heterologous expression systems to eliminate functional redundancy

This systematic approach helps distinguish between true biological effects and technical artifacts, similar to strategies used to confirm SdrD-Dsg1 interactions through multiple complementary methods .

What statistical approaches are most appropriate for analyzing Recombinant Staphylococcus aureus 60 kDa chaperonin (groL) experimental data?

Statistical analysis of experimental data involving Recombinant Staphylococcus aureus 60 kDa chaperonin (groL) should be tailored to the specific experimental design:

  • For completely randomized designs:

    • Analysis of Variance (ANOVA) for comparing multiple treatment groups

    • Student's t-test for two-group comparisons (used in SdrD-Dsg1 binding studies)

    • Post-hoc tests (e.g., Tukey's) for multiple comparisons

    • Set significance threshold appropriately (typically p < 0.05)

  • For randomized block designs:

    • Two-way ANOVA incorporating blocking factors

    • Mixed-effects models for complex experimental structures

    • Analysis of covariance (ANCOVA) when controlling for continuous variables

  • For repeated measures designs:

    • Repeated measures ANOVA

    • Linear mixed models to account for missing data

Ensure adequate statistical power through appropriate sample size determination before experiments begin, and report effect sizes along with p-values to indicate biological significance beyond statistical significance .

How can I integrate findings about Recombinant Staphylococcus aureus 60 kDa chaperonin (groL) into broader understanding of staphylococcal pathogenesis?

To integrate findings about Recombinant Staphylococcus aureus 60 kDa chaperonin (groL) into the broader context of staphylococcal pathogenesis, consider the following analytical framework:

  • Comparative analysis with other staphylococcal proteins:

    • Functional similarities to other chaperonins

    • Structural homology to known virulence factors

    • Evolutionary conservation across staphylococcal species

  • Contextualization within host-pathogen interaction networks:

    • Potential roles in adhesion and invasion processes

    • Immunomodulatory effects

    • Contribution to biofilm formation or antibiotic resistance

  • Integration with signaling pathway analyses:

    • Impact on host cellular pathways (e.g., Rho signaling pathway affected by Dsg1)

    • Effects on cytoskeletal organization and cell migration

    • Potential influence on host cell differentiation

This integrative approach has proven valuable for understanding other staphylococcal proteins like SdrD, where interaction with Dsg1 was placed in context of potential effects on keratinocyte differentiation and Rho signaling pathways that influence cytoskeleton and cell migration .

What are the most critical considerations for researchers working with Recombinant Staphylococcus aureus 60 kDa chaperonin (groL)?

Researchers working with Recombinant Staphylococcus aureus 60 kDa chaperonin (groL) should prioritize several critical factors for successful experimental outcomes:

  • Protein integrity maintenance:

    • Proper storage conditions (-20°C/-80°C for long-term)

    • Avoidance of repeated freeze-thaw cycles

    • Careful reconstitution with appropriate buffers

    • Addition of glycerol (5-50%) for stability

  • Experimental design rigor:

    • Comprehensive controls (positive, negative, vehicle)

    • Randomization strategies to minimize bias

    • Statistical power calculations before experimentation

    • Multiple complementary methodologies for key findings

  • Functional analysis contexts:

    • Consideration of both intracellular and potential extracellular roles

    • Heterologous expression systems to overcome functional redundancy

    • Integration of findings with broader staphylococcal biology

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.